Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1414 studies found for:    "Multiple Sclerosis"
Show Display Options
Rank Status Study
1 Terminated Memantine Therapy for Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Memantine;   Drug: Placebo
2 Completed Constraint-Induced (CI) Movement Therapy for Progressive Multiple Sclerosis (MS)
Condition: Multiple Sclerosis
Intervention: Behavioral: Constraint-Induced Movement Therapy
3 Completed Sodium Intake in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention:
4 Completed Testosterone Treatment for Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: Androgel 100mg gel
5 Recruiting Phase 2 Study of Ublituximab in Patients With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: Ublituximab;   Drug: Placebo
6 Withdrawn Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in Life
Condition: Multiple Sclerosis
Intervention:
7 Completed
Has Results
Duloxetine for Multiple Sclerosis Pain
Condition: Multiple Sclerosis
Interventions: Drug: Duloxetine Hydrochloride (HCI);   Drug: Placebo
8 Completed Efficacy, Safety, and Tolerability of Nerispirdine in Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Nerispirdine;   Drug: placebo
9 Completed Low Fat Diet and Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: Low fat study diet
10 Unknown  Characteristic Study on Chinese Patients With Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: atorvastatin;   Drug: β-interferon;   Drug: EPO
11 Recruiting Oral Ponesimod Versus Teriflunomide In Relapsing MUltiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: ponesimod;   Drug: teriflunomide
12 Completed
Has Results
An Efficacy Study of Teriflunomide in Participants With Relapsing Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Drug: Placebo;   Drug: Teriflunomide
13 Completed
Has Results
Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Biological: Interferon-beta-1a FBS-free/HSA-free
14 Completed
Has Results
12-week Study to Evaluate RebiSmart™ Suitability for Self Injection in Relapsing Multiple Sclerosis.
Condition: Multiple Sclerosis
Intervention: Drug: Rebif® New Formulation (RNF) using RebiSmartTM
15 Terminated Study to Evaluate Intravenous and Oral Steroids for Multiple Sclerosis Attacks
Condition: Multiple Sclerosis
Interventions: Drug: megadose oral methylprednisolone;   Drug: IV methylprednisolone
16 Not yet recruiting Use of an Electronic Diary by People With Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Device: e-diary
17 Completed Integrative Group-based Cognitive Rehabilitation Efficacy in Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Other: cognitive remediation program: REHACOP
18 Completed Evaluation of Autologous Mesenchymal Stem Cell Transplantation (Effects and Side Effects) in Multiple Sclerosis
Condition: Multiple Sclerosis
Interventions: Biological: intravenous injection of mesenchymal stem cells;   Biological: injection of cell free media
19 Not yet recruiting A Study to Evaluate the Safety of Long Term Treatment With Teriflunomide 14 mg Once Daily in Patients With a First Clinical Episode Suggestive of Multiple Sclerosis in a Long-term Extension Period
Condition: Multiple Sclerosis
Intervention: Drug: Teriflunomide
20 Suspended [11C]-PBR28 Positron Emission Tomography Study to Evaluate the Effect of ABT 555 in Subjects With Relapsing Forms of Multiple Sclerosis
Condition: Multiple Sclerosis
Intervention: Drug: ABT-555

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.